Merck (NYSE: MRK) and Eisai announced that the U.S. Food and Drug Administration has approved a combination of belzutifan (Welireg) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE